Corvex Management Q1 2026 13F Holdings and Activity Report

I. Institutional Overview

As of the first quarter of 2026, the investment landscape for Corvex Management LP, led by the astute Keith Meister, presents a fascinating study in high-conviction, activist-oriented portfolio management. With a total reported portfolio market value of approximately $2.52 billion, Corvex continues to operate as a mid-sized but highly influential player in the hedge fund space. Keith Meister, a well-known protégé of the legendary Carl Icahn, has infused Corvex with a philosophy that prioritizes deep fundamental research, strategic engagement with management teams, and a willingness to maintain a concentrated book of business.

The scale of the institution has remained relatively stable, with a portfolio value hovering around the $2.5 billion mark. This stability suggests a disciplined approach to assets under management, focusing on performance rather than aggressive capital gathering. The institutional portrait that emerges is one of a "surgical" investor—one who waits for the right opportunity to strike and then commits heavily. Whether it is navigating the complexities of the healthcare sector or identifying undervalued assets in the consumer discretionary space, Corvex’s current posture reflects a blend of opportunistic aggression and calculated patience.

This section shows only part of the complete report. View the app for the full analysis, position-level detail, and quarter-over-quarter tracking.

II. Sector Allocation Analysis

A key observation in this quarter's data is the relative underweighting of the Technology sector, which stands at a mere 2.16%. In an era where many institutional investors are heavily overweight in "Magnificent Seven" style tech stocks, Corvex’s decision to keep tech exposure minimal—and even reduce positions in giants like Microsoft and Amazon—is a bold contrarian signal. It suggests a judgment that the technology sector may be overvalued or that the "easy money" has already been made, prompting a rotation into sectors with more tangible value-unlocking catalysts.

From this allocation, we can infer that Corvex is positioning itself for a "stock-picker's market" rather than a broad-based rally. The heavy tilt toward Healthcare and specialized Consumer plays suggests a focus on idiosyncratic growth—growth that comes from company-specific breakthroughs or strategic pivots rather than general economic expansion. The firm appears to be moving away from the "beta" of the tech sector and toward the "alpha" of complex, event-driven situations. This is a sophisticated defensive-offensive hybrid posture: defensive in its avoidance of overextended tech valuations, but offensive in its concentrated bets on specific industry leaders.

This section shows only part of the complete report. View the app for the full analysis, position-level detail, and quarter-over-quarter tracking.

III. Top 10 Holdings Deep Dive

Illumina remains the undisputed heavyweight in the Corvex portfolio, representing nearly 19% of total assets. This is a classic "conviction holding" that stems from a long-standing activist engagement. Corvex has historically pushed for significant changes at Illumina, including the divestiture of Grail and a refocusing on the core DNA sequencing business. The fact that the number of shares held remained unchanged this quarter, while the portfolio weight increased from 15.35% to 18.77%, suggests that the stock's price performance outperformed the rest of the portfolio. This indicates that the market is beginning to validate Corvex's thesis on the company's turnaround. For Corvex, Illumina is not just a stock; it is a multi-year strategic project. The firm is betting that as the leader in genomic sequencing, Illumina will benefit from the long-term trend of personalized medicine and that a leaner, more focused corporate structure will drive significant margin expansion.

This section shows only part of the complete report. View the app for the full analysis, position-level detail, and quarter-over-quarter tracking.

IV. Major Buys/Additions

The most significant new position this quarter is CoStar Group, with an estimated investment of $34.36 million. This move into the real estate data and marketplace giant is a classic "growth acceleration bet." CoStar has a dominant position in commercial real estate data and is aggressively expanding into the residential market. By initiating this position, Corvex is likely betting on the company's ability to disrupt the traditional residential real estate portal landscape. The valuation of CoStar is often high, but its competitive moat is incredibly wide. This addition suggests that Corvex is looking for "compounders"—companies that can grow their earnings consistently over a long horizon regardless of the macro environment.

This section shows only part of the complete report. View the app for the full analysis, position-level detail, and quarter-over-quarter tracking.

V. Major Sells and Exits

The complete liquidation of the Oracle position is the most significant "sell" signal of the quarter. With an estimated realized amount of over $78 million, this was a major exit. Oracle has been a beneficiary of the AI-driven cloud boom, and its stock price has reflected that optimism. Corvex’s decision to "sell all" suggests a belief that the stock has reached full valuation or that the competitive pressures in the cloud space are intensifying. This is a "logical clearing"—the investment thesis has likely played out, and Corvex is moving on to the next opportunity. It marks a clear exit from the "Big Tech AI" trade that dominated the previous year.

This section shows only part of the complete report. View the app for the full analysis, position-level detail, and quarter-over-quarter tracking.

VI. Investment Insights and Risk Warnings

The logic chain is clear: 1. Sold what: High-valuation tech (Oracle, Microsoft) and macro-sensitive cyclicals (Union Pacific, Restaurant Brands). 2. Why sell: To lock in profits from the AI and post-pandemic recovery rallies and to reduce exposure to broad economic volatility. 3. Bought what: Strategic media (Disney, Lionsgate), dominant data platforms (CoStar), and genomic innovators (GeneDx). 4. Why buy: To capture "alpha" from specific corporate turnarounds, industry disruptions, and long-term scientific trends that are less dependent on the general macro-economic cycle. 5. Overall change: The portfolio has become more concentrated in "event-driven" stories.

For retail investors, the reference value here is the importance of active pruning . Even a high-conviction manager like Meister doesn't hold forever; he is constantly assessing whether a stock's current price reflects its future potential. The move into Disney and CoStar suggests that "value" is now found in high-quality brands and data moats that have been temporarily overlooked or mispriced by the market. However, it is important to note that many of Corvex's moves are tied to its role as an activist. Retail investors cannot easily replicate the "activist premium" that Corvex creates through direct engagement with management.

This section shows only part of the complete report. View the app for the full analysis, position-level detail, and quarter-over-quarter tracking.

Sources and limitations

This report uses public U.S. Securities and Exchange Commission Form 13F disclosures and structured data maintained by 13F Hub. A 13F filing is a quarter-end snapshot of reportable long positions, is normally published with a delay, and does not disclose every short position, cash balance, bond, derivative, or non-U.S. asset.

Narrative content is prepared from the same-period SEC disclosure and 13F Hub structured data, then checked before publication. This material is for research and education, not personalized investment advice.